Considering the time of year, I would suggest we ask Reggie's opinion on this :-)
Seriously though, much of what we do is evaluate conditional situations. Should we wait until a drug is approved to debate its commercial value?
I am in the long term camp, so for me I can just wait. Not worth the effort to worry about it when we have a decision shortly. But some trade, and trading a judicial decision is just as rational as trading an FDA action.